Skip to main content
Clinical Trials/NCT04979182
NCT04979182
Unknown
Not Applicable

Somatic and Neurobehavioral Clinical Characterization of Frequent Monogenic Forms of Neurodevelopmental Disorders

University Hospital, Strasbourg, France1 site in 1 country30 target enrollmentMay 15, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Neurodevelopmental Disorders
Sponsor
University Hospital, Strasbourg, France
Enrollment
30
Locations
1
Primary Endpoint
Study of clinical profiles associated to different monogenic form of NDD
Last Updated
4 years ago

Overview

Brief Summary

The main objective is to constitute a precise and exhaustive collection of clinical data (somatic and neurobehavioral data) of individuals affected by various frequent monogenic forms of neurodevelopmental disorders to better characterize the clinical phenotype of these disorders.

A better knowledge of these manifestations is necessary to improve the management of individuals with these disorders.

The secondary objectives of this research are to inform practitioners, patients and their families about the clinical characteristics of these disorders to better understand their diversity and, finally, to improve their screening and diagnosis. Thus, our study aims at establishing clinical scores, linking genotypes and phenotypes and producing documents for professionals (such as the PNDS (National Diagnostic and Care Protocols))

Registry
clinicaltrials.gov
Start Date
May 15, 2021
End Date
May 2024
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Strasbourg, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Study of clinical profiles associated to different monogenic form of NDD

Time Frame: Files analysed retrospectively from January 01, 2015 to March 31, 2020 will be examined]

Study Sites (1)

Loading locations...

Similar Trials